folder

Non-coding deletions identify Maenli lncRNA as a limb-specific En1 regulator

Authors

  • L. Allou
  • S. Balzano
  • A. Magg
  • M. Quinodoz
  • B. Royer-Bertrand
  • R. Schöpflin
  • W.L. Chan
  • C.E. Speck-Martins
  • D.R. Carvalho
  • L. Farage
  • C.M. Lourenço
  • R. Albuquerque
  • S. Rajagopal
  • S. Nampoothiri
  • B. Campos-Xavier
  • C. Chiesa
  • F. Niel-Bütschi
  • L. Wittler
  • B. Timmermann
  • M. Spielmann
  • M.I. Robson
  • A. Ringel
  • V. Heinrich
  • G. Cova
  • G. Andrey
  • C.A. Prada-Medina
  • R. Pescini-Gobert
  • S. Unger
  • L. Bonafé
  • P. Grote
  • C. Rivolta
  • S. Mundlos
  • A. Superti-Furga

Journal

  • Nature

Citation

  • Nature 592 (7852): 93-98

Abstract

  • Long non-coding RNAs (lncRNAs) can be important components in gene-regulatory networks, but the exact nature and extent of their involvement in human Mendelian disease is largely unknown. Here we show that genetic ablation of a lncRNA locus on human chromosome 2 causes a severe congenital limb malformation. We identified homozygous 27-63-kilobase deletions located 300 kilobases upstream of the engrailed-1 gene (EN1) in patients with a complex limb malformation featuring mesomelic shortening, syndactyly and ventral nails (dorsal dimelia). Re-engineering of the human deletions in mice resulted in a complete loss of En1 expression in the limb and a double dorsal-limb phenotype that recapitulates the human disease phenotype. Genome-wide transcriptome analysis in the developing mouse limb revealed a four-exon-long non-coding transcript within the deleted region, which we named Maenli. Functional dissection of the Maenli locus showed that its transcriptional activity is required for limb-specific En1 activation in cis, thereby fine-tuning the gene-regulatory networks controlling dorso-ventral polarity in the developing limb bud. Its loss results in the En1-related dorsal ventral limb phenotype, a subset of the full En1-associated phenotype. Our findings demonstrate that mutations involving lncRNA loci can result in human Mendelian disease.


DOI

doi:10.1038/s41586-021-03208-9